Marc Semigran - Net Worth and Insider Trading

Marc Semigran Net Worth

The estimated net worth of Marc Semigran is at least $193,018 dollars as of 2024-12-28. Marc Semigran is the Chief Development Officer of Edgewise Therapeutics Inc and owns about 6,716 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $193,018. Marc Semigran is also the Chief Medical Officer of MyoKardia Inc and owns about 0 shares of MyoKardia Inc (MYOK) stock worth over $0. Details can be seen in Marc Semigran's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marc Semigran has not made any transactions after 2024-12-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Marc Semigran

To

Marc Semigran Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marc Semigran owns 6 companies in total, including MyoKardia Inc (MYOK) , Renovacor Inc (RCOR) , and Social Capital Suvretta Holdings Corp III (DNAC) among others .

Click here to see the complete history of Marc Semigran’s form 4 insider trades.

Insider Ownership Summary of Marc Semigran

Ticker Comapny Transaction Date Type of Owner
MYOK MyoKardia Inc 2019-02-08 Chief Medical Officer
RCOR Renovacor Inc 2021-09-02 Chief Medical Officer
DNAC Social Capital Suvretta Holdings Corp III 2021-06-29 director
LIMIT LIMIT 2021-06-29 director
LIMIT LIMIT 2022-12-19 Chief Development Officer
LIMIT LIMIT 2021-09-02 Chief Medical Officer

Marc Semigran Latest Holdings Summary

Marc Semigran currently owns a total of 2 stocks. Among these stocks, Marc Semigran owns 6,716 shares of Edgewise Therapeutics Inc (EWTX) as of December 24, 2024, with a value of $193,018 and a weighting of 100%. Marc Semigran also owns 0 shares of MyoKardia Inc (MYOK) as of September 5, 2018, with a value of $0 and a weighting of 0%.

Latest Holdings of Marc Semigran

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EWTX Edgewise Therapeutics Inc 2024-12-24 6,716 28.74 193,018
MYOK MyoKardia Inc 2018-09-05 0 224.91 0

Holding Weightings of Marc Semigran


Marc Semigran Form 4 Trading Tracker

According to the SEC Form 4 filings, Marc Semigran has made a total of 1 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Edgewise Therapeutics Inc is the sale of 29,709 shares on December 24, 2024, which brought Marc Semigran around $882,060.

According to the SEC Form 4 filings, Marc Semigran has made a total of 0 transactions in MyoKardia Inc (MYOK) over the past 5 years. The most-recent trade in MyoKardia Inc is the sale of 45,000 shares on September 5, 2018, which brought Marc Semigran around $3 Million.

Insider Trading History of Marc Semigran

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marc Semigran Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Marc Semigran Ownership Network

Ownership Network List of Marc Semigran

No Data

Ownership Network Relation of Marc Semigran

Insider Network Chart

Marc Semigran Owned Company Details

What does MyoKardia Inc do?

Who are the key executives at MyoKardia Inc?

Marc Semigran is the Chief Medical Officer of MyoKardia Inc. Other key executives at MyoKardia Inc include director & President and CEO Anastasios Gianakakos , General Counsel Denelle J Waynick , and Chief Business Officer Jake Bauer .

MyoKardia Inc (MYOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

MyoKardia Inc Insider Transactions

No Available Data

Marc Semigran Mailing Address

Above is the net worth, insider trading, and ownership report for Marc Semigran. You might contact Marc Semigran via mailing address: C/o Myokardia, Inc., 333 Allerton Ave, South San Francisco Ca 94080.

Discussions on Marc Semigran

No discussions yet.